BSE filing, NSE: AYMSYNTEX. Summary written from the filing by ALFA Finder's alert engine.
AYM Syntex Ltd: key numbers
- Share price
- ₹244.10
- Market cap
- ₹1,435 Cr
- Revenue (annual)
- ₹1,365 Cr
- Net profit (annual)
- ₹6.55 Cr
- P/E (TTM)
- 76.5×Sector 49.5×
- Promoter holding
- 65.67%-0.06% QoQ
- FII holding
- 3.71%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from AYM Syntex Ltd
All →AYM Syntex Board Meeting Date
AYM Syntex Ltd will hold a board meeting on October 29, 2026, to approve the standalone and consolidated financial results for the quarter ended September 30, 2026.
AYM Syntex Legal & Regulatory
AYM Syntex received a GST show cause notice for F.Y. 2022-23 totaling ₹2.32 Crore, including tax, interest, and penalty. The company is evaluating the notice.
- Value
- ₹2.32 Cr
- From
- Department of Goods and Services Tax, Government of Maharashtra
AYM Syntex Annual General Meeting
AYM Syntex held its 43rd Annual General Meeting to transact routine business, including the adoption of financial statements and the approval of director remuneration.
AYM Syntex Capital Structure Change
Designated Person Rahul Pareek sold 20,500 equity shares of AYM Syntex Ltd via market sale for Rs. 0.64 Crore.
- Value
- ₹0.64 Cr
AYM Syntex Other Announcement
Designated Person Rahul Pareek sold 20,500 equity shares of AYM Syntex Ltd for ₹0.64 Crore. This transaction was executed on the NSE.
- Value
- ₹0.64 Cr
AYM Syntex Annual General Meeting
AYM Syntex Limited has issued a notice for its 43rd Annual General Meeting to be held on September 28, 2026, via video conferencing.
- Value
- ₹0.19 Cr
Other other announcement announcements
All →eMudhra Other Announcement
eMudhra Ltd disclosed that SES ESG revised its ESG score from 68.0 to 64.9 in its ESG Report 2026. The company states it did not engage SES ESG, and the revision relates to its certificate business.
Aarti Pharmalabs Other Announcement
Aarti Pharmalabs has intimated under Regulation 46 that it revamped its website at the existing URL to improve design and accessibility. The notice has no financial or business substance.
Sagarsoft (India) Other Announcement
Sagarsoft (India) filed its Regulation 32 fund utilisation statement for its 2021 preferential issue. No deviation was reported and the full Rs.5.08 Crore was used.
Sadhana Nitro Chem Other Announcement
Sadhana Nitro Chem reported no deviation in use of its preferential issue proceeds for the quarter ended September 2026. The Audit Committee reviewed the statement.
Shriram Asset Management Company Other Announcement
Shriram AMC filed ICRA's quarterly monitoring agency report on preferential issue proceeds. Utilisation is in line with the offer objects, with no deviation reported.
Jhandewalas Foods Other Announcement
Jhandewalas Foods filed its quarterly shareholding pattern for the period ended September 30, 2026. The filing records holdings by category and contains no transaction or money event.